Quantcast
Last updated on April 24, 2014 at 11:24 EDT

Latest Papillary thyroid cancer Stories

2011-12-20 22:42:34

Procedure may reduce recurrence rates, lower tumor marker levels Papillary thyroid cancer accounts for the majority of all thyroid malignancies, which primarily impact women. A new study indicates that routinely removing lymph nodes in the neck in these cancer patients may help prevent the disease from coming back. When thyroid cancer metastasizes, lymph nodes in the neck may be affected, but these lymph-node tumors can be tiny and may not be detected by ultrasounds done before surgery...

2011-11-22 08:26:20

(Ivanhoe Newswire) — Papillary carcinoma is the most common type of thyroid cancer, and about one fourth of these carcinomas have mutations in the BRAF gene. These mutations are most common in high-grade carcinomas, in particular, the ones that resist standard treatments. According to researchers at Memorial Sloan-Kettering Cancer Center, New York, exploiting the expression of BRAF by the resistant cancers could be a therapeutic advantage. Despite the prevalence of BRAF mutations in...

2011-11-21 23:09:28

Papillary carcinoma is the most common form of thyroid cancer. Approximately one quarter of these carcinomas have mutations in the BRAF gene. The prevalence of such mutations is even greater in high-grade carcinomas, particularly those that are refractory to standard treatment, which is radioactive iodine (RAI). A team of researchers led by James Fagin, at Memorial Sloan-Kettering Cancer Center, New York, has now identified a way to potentially exploit the expression of BRAF by such cancers...

2011-11-10 09:00:00

SARASOTA, Fla., Nov. 10, 2011 /PRNewswire/ -- Amy Murray, a 35-year old mother of two, had a sore throat for weeks. When she begun to have trouble swallowing, she thought she might have strep throat, and went to see her doctor. He found a lump in her neck, and after several medical tests, Murray was diagnosed with papillary thyroid cancer. According to TMD Limited, a medical research company, Murray's research and ultimate decision to seek treatment outside of the US is typical of more...

2011-04-13 21:10:58

Surgical approaches that reduce incision size and recovery time from thyroid surgery work well in children, physician-scientists report. "It brings parents comfort to know it's going to be a small incision, an outpatient surgery with no drains or staples on the skin. We just use some glue for the skin and the recovery is very rapid," said Dr. David Terris, Chairman of the Department of Otolaryngology-Head and Neck Surgery at Georgia Health Sciences University. The results should bring comfort...

2010-09-22 09:51:39

(Ivanhoe Newswire) -- The results are in.  After a phase 2 trial, 49 percent of patients with advanced differentiated thyroid cancers responded to treatment using a drug designed to stop tumor blood vessel growth.  The name of drug that has shown the highest response of any treatment to date for advanced thyroid cancer: pazopanib.  The estimated time two-thirds of these patients are likely to have a response to the drug: 1 year or longer.  With the incidence of thyroid...

2010-05-18 12:28:01

Individuals with papillary thyroid cancer that has not spread beyond the thyroid gland appear to have favorable outcomes regardless of whether they receive treatment within the first year after diagnosis, according to a report in the May issue of Archives of Otolaryngology"“Head & Neck Surgery, one of the JAMA/Archives journals. Papillary thyroid cancer is commonly found on autopsy among individuals who died of other causes, according to background information in the article....

2009-11-06 12:43:13

People living in volcanic areas may be at a higher risk for thyroid cancer, according to a new study published online November 5 in the Journal of the National Cancer Institute. The increasing incidence of thyroid cancer has been attributed to more sensitive screening, but recent evidence indicates that this may not be the only cause. Various environmental factors, such as those associated with volcanoes, have not been excluded as risk factors. To study this, Gabriella Pellegriti, M.D.,...

2009-05-18 12:21:00

ORLANDO, May 18 /PRNewswire-USNewswire/ -- A medication that helps stop the growth of new blood vessels has produced dramatic benefits for some patients with aggressive thyroid cancer, research from Mayo Clinic indicates. At the annual meeting of the American Society of Clinical Oncology (ASCO), Mayo investigators report that cancer in about two-thirds of 37 patients with aggressive differentiated thyroid cancer treated with the drug pazopanib either stopped growing, or quickly shrank. The...

2008-08-30 09:00:24

By Montone, Kathleen T Baloch, Zubair W; LiVolsi, Virginia A Context.-Hurthle cells are eosinophilic, follicular-derived cells that are associated with a variety of nonneoplastic and neoplastic thyroid lesions. The differential diagnosis of Hurthle cell lesions is quite broad. Objective.-To review the pathologic conditions associated with Hurthle cells in the thyroid and to discuss pathology of thyroid lesions associated with oncocytic cytology. Data Sources.-A variety of thyroid...